Overview
Updated 14 Jul 2026
Kevin D. Deane, MD, is Professor of Medicine, Division of Rheumatology (William P. Arend Endowed Chair in Rheumatology Research) at University of Colorado Anschutz Medical Campus, School of Medicine, Division of Rheumatology. The public record shows 253 publications with 14,834 citations (h-index 61), centered on Rheumatoid Arthritis. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 5 companies, 4 NIH-funded awards (2004–2026).
- Most recent indexed publication: 2026 · Arthritis & rheumatology (Hoboken, N.J.)
- Top research focus: Rheumatoid Arthritis
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 5 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 40 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease
Sponsor: University of Colorado, Denver
InvestigatorRecruitingNCT03297775 - Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
InvestigatorPhase 2TerminatedNCT02603146
Industry payments
Updated 14 Jul 2026
5 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20252 payments
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
- Janssen Biotech, Inc.Program year20251 payment
NIH funding
Updated 14 Jul 2026
4 NIH research awards on record, funded 2004–2026 per NIH RePORTER. The latest:
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- A Phase 2 Trial of Hydroxychloroquine in Individuals at Risk for Rheumatoid Arthritis.
Arthritis & rheumatology (Hoboken, N.J.)
2026 - EULAR/American College of Rheumatology Risk Stratification Criteria for Development of Rheumatoid Arthritis in the Risk Stage of Arthralgia.
Arthritis & rheumatology (Hoboken, N.J.)
2026
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
Barbara Davis Center for Diabetes, 1775 North Aurora Court, Suite 3102, Aurora, CO 80045
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
Editorial & leadership rolesjournal and society appointments
- Principal Investigator
StopRA (NIH/NIAID-sponsored trial evaluating hydroxychloroquine to prevent/delay rheumatoid arthritis in high-risk individuals)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uchealth.org ↗ - Member
American College of Rheumatology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →som.cuanschutz.edu ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
Secondary affiliationsappointments beyond the home institution
- Population and Data Sciences Core Service Center (PDSC)
Division of Rheumatology, CU Anschutz
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medschool.cuanschutz.edu ↗
Media & interviewspress, podcasts and appearances
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healio.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healio.com ↗
- Author
"Rheumatoid arthritis has no cure – but researchers are homing in on preventing it," The Conversation (republished by CU Anschutz News, Yahoo Health, Study Finds, Japan Today)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →theconversation.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- ResearchGate
researchgate.net/profile/Kevin-Deane-2
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by otherswhere others cite or feature them
- Other
rheumnow.live/b/sp/kevin-deane-1263
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rheumnow.live ↗ - Other
healio.com/news/rheumatology/20250124/hooked-on-rheum-with-kevin-d-deane-md-phd
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healio.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Daniel Pollyea, MD
University of Colorado Anschutz Medical Campus
- 558
- publications
- 70
- h-index
- 10
- trials
Gregory Forlenza, MD
University of Colorado Anschutz Medical Campus
- 295
- publications
- 58
- h-index
- 9
- trials